Global provider of drug development solutions and services, ICON plc ICLR, recently announced the launch of the Firecrest Patient portal. The portal is designed to assist patients in viewing and ...

New solutions enable enhanced delivery, tracking and management of drug safety reporting and medical questions from sites DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider of drug ...

ICON has expanded its capacity to drive study quality and efficacy in clinical research by acquiring fellow Irish company Firecrest Clinical. ICON has expanded its capacity to drive study quality and ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today ...

Dublin-based Icon said the Firecrest acquisition will expand the range of development services it can offer to the pharmaceutical, biotechnology and medical device industries. Firecrest’s technology ...

Signing up patients for clinical trials has become a major problem for the pharma sector. At present, the main means of clinical trial recruitment is a poster on a hospital wall. It is therefore ...

New Firecrest Patient Portal, part of ICONIK Informatics Hub, designed to enhance patient engagement and support patient recruitment and retention. DUBLIN--ICON plc, (NASDAQ: ICLR) a global provider ...

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of two new digital ...